Erratum (DOI:10.1016/j.bbmt.2008.06.012);Response to Pneumococcal (PNCRM7) and Haemophilus Influenzae Conjugate Vaccines (HIB) in Pediatric and Adult Recipients of an Allogeneic Hematopoietic Cell Transplantation (alloHCT)

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 9, 2008, Pages 1022-1030

  Pao, Mary ^a   Papadopoulos, Esperanza B ^a   Chou, Joanne ^a   Glenn, Heller ^a   Castro Malaspina, Hugo ^a   Jakubowski, Ann A ^a   Kernan, Nancy A ^a   Perales, Miguel A ^a   Prokop, Susan ^a   Scaradavou, Andromachi ^a   vanDenBrink, Marcel R ^a   Young, James W ^a   O'Reilly, Richard J ^a   Small, Trudy N ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Haemophilus influenzae; Pneumococcus; Vaccination

Indexed keywords

ALEMTUZUMAB; CD4 ANTIGEN; CD45RA ANTIGEN; CYCLOSPORIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G; METHOTREXATE; PHYTOHEMAGGLUTININ; PNCRM 7; PNEUMOCOCCUS VACCINE; RITUXIMAB; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LEUKEMIA; CONTROLLED STUDY; CORRELATION FUNCTION; DONOR LYMPHOCYTE INFUSION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOGENICITY; INFANT; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS INFECTION; UNSPECIFIED SIDE EFFECT; VACCINATION; WHOLE BODY RADIATION;

EID: 49449103359     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.09.016     Document Type: Erratum

References (45)

1. Kulkarni S., Powles R., Treleaven J., et al. Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood 95 (2000) 3683-3686
2. Engelhard D., Cordonnier C., Shaw P.J., et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol 117 (2002) 444-450
3. Socie G., Salooja N., Cohen A., et al. Non-malignant late effects after allogeneic stem cell transplantation. Blood 101 (2003) 3373-3385
4. Chen C.S., Boeckh M., Seidel K., et al. Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplant 32 (2003) 515-522
5. Youssef S., Rodriguez G., Rolston K.V., et al. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005. Medicine 86 (2007) 69-77
6. Kumar D., Humar A., Plevneshi A., et al. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant 41 (2008) 743-747
7. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR 49 (2000) 1-128
8. Ljungman P., Engelhard D., de la Cámara R., et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 35 (2005) 737-746
9. Guinan E.C., Molrine D.C., Antin J.H., et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 57 (1994) 677-684
10. Parkkali T., Kayhty H., Ruutu T., et al. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Bone Marrow Transplant 18 (1996) 961-967
11. Pao M.K., Papadopoulos E.B., Kernan N.A., et al. Immunogenicity of haemophilus influenza and pneumococcal vaccines in related and unrelated transplant recipients. Blood 108 (2006) 178a
12. Black S., Shinefield H., Fireman B., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 10 (2000) 187-195
13. Hsu K., Pelton S., Karumuri S., Heisey-Grove D., and Klein J. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr Infect Dis J 24 (2005) 17-23
14. Prevention of Pneumococcal Disease. Recommendations of the Advisory Committee on on Immunization Practices (ACIP). MMWR 46 (1997) 1-24
15. Whitney C.G., Farley M.M., Hadler J., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Eng J Med 348 (2003) 1737-1746
16. Small T.N., Keever C.A., Weiner-Fedus S., et al. B cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B cell ontogeny. Blood 76 (1990) 1647-1656
17. Rowlings P.A., Przepiorka D., Klein J.P., et al. IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 97 (1997) 855-864
18. Sullivan K.M., Shulman H.M., Storb R., et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 57 (1981) 267-276
19. Small T.N., Papadopoulos E.B., Boulad F., et al. Comparison of immune reconstitution following unrelated and related T cell depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 93 (1999) 467-480
20. Reisner Y., Kapoor N., Kirkpatrick D., et al. Transplantation for severe combined immunodeficiency disease with HLA-A, B,D,DR incompatible parental marrow cells fractionated by soybean agglutination and sheep red blood cells. Blood 61 (1983) 341-348
21. Jakubowski A.A., Small T.N., Young J.W., et al. T cell-depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood 110 (2007) 4552-4559
22. Hosmer D.W., and Lemeshow S. A goodness-of-fit test for the multiple logistic regression model. Commun Stat A10 (1980) 1043-1069
23. Papdopoulos E.B., Carabasi M.H., Castro-Malaspina H., et al. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood 91 (1998) 1083-1090
24. Weisdorf D.J., Anasetti C., Antin J.H., et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood 99 (2002) 1971-1977
25. Alyea E.P., Weller E., Fisher D.C., et al. Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 8 (2002) 601-607
26. Moore J., Nivison-Smith I., Goh K., et al. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia. Biol Blood Marrow Transplant 13 (2007) 601-607
27. Weisser M., Schleuning M., Haferlach C., Schwerdtfeger R., and Kolb H.J. Allogeneic stem-cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant Imatinib therapy. Leuk Lymphoma 48 (2007) 295-301
28. Oran B., Giralt S., Saliba R., et al. Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan. Biol Blood Marrow Transplant 13 (2007) 454-462
29. Giles F.J., Borthakur B., Ravandi F., et al. The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia. Br J Haematol 136 (2007) 624-627
30. Escalón M.P., Champlin R.E., Saliba R.M., et al. Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation. J Clin Oncol 22 (2004) 2419-2423
31. Barra A., Cordonnier C., Preziosi M.-P., et al. Immunogenicity of haemophilus influenza type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 166 (1992) 1021-1028
32. Molrine D.C., Antin J.H., Guinan E.C., et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 101 (2003) 831-836
33. Kumar D., Chen M.H., Welsh B., et al. A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. CID 45 (2007) 1576-1582
34. Storek J., Dawson M.A., and Lim L.C. Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation. Bone Marrow Transplant 33 (2004) 337-346
35. Meisel R., Kuypers L., Dirksen U., et al. Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell Transplantation. Blood 109 (2007) 2322-2326
36. Patel S.R., Ortín M., Cohen B.J., et al. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis 44 (2007) 625-634
37. Royal College of Paediatrics and Child Health (RCPCH). Immunisation of the Immunocompromised Child: Best Practice Statement (2002), RCPCH, London 10-13
38. Örtqvist A., Hedlund J., Burman L.-A., et al. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 351 (1998) 399-403
39. Storek J., Joseph A., Dawson M.A., Douek D.C., Storer B., and Maloney D.G. Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation. Transplantation 73 (2002) 1154-1158
40. Avanzini M., Locatelli F., Santos C., et al. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27 B cells. Exp Hematol 33 (2005) 480-486
41. Jaffe D., Papadopoulos E.B., Young J.W., et al. Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell transplantation (HCT). Blood 108 (2006) 2470-2475
42. Kyaw M.H., Lynfield R., and Schaffner W. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354 (2006) 1455-1463
43. Alpdogan O., and van den Brink M.R. IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol 26 (2005) 56-64
44. Kundi M. New hepatitis B vaccine formulated with an improved adjuvant system. Expert Rev Vaccines 6 (2007) 133-140
45. Scott D.A., Komjathy S.F., Hu B.T., et al. Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults. Vaccine 25 (2007) 6164-6166